Chow, Eric P. F. Hocking, Jane S. Ong, Jason J. Phillips, Tiffany R. Schmidt, Tina Buchanan, Andrew Rodriguez, Elena Maddaford, Kate Fairley, Christopher K.
Published in
Journal of Acquired Immune Deficiency Syndromes (1999)
A second wave of COVID-19 began in late June in Victoria, Australia. Stage 3 then Stage 4 restrictions were introduced in July–August. This study aimed to compare the use of pre-exposure prophylaxis (PrEP) and sexual practices among men who have sex with men taking PrEP between May–June (post-first lockdown) and July–August (second lockdown). Metho...
Schneider, John A Young, Lindsay Ramachandran, Arthi Michaels, Stuart Cohen, Hildie Robinson, Ishida Alon, Leigh Hill, Brandon Nakasone, Sarah Balenciaga, Mario
...
Published in
Journal of acquired immune deficiency syndromes (1999)
We tested preliminary efficacy of a peer change agent type I network intervention to increase pre-exposure prophylaxis (PrEP) linkage to care among network members connected to young Black men who have sex with men. Parent study is a pragmatic randomized controlled trial with 110 weeks of total follow-up. Interim midpoint analyses are performed her...
Mody, Aaloke Sikombe, Kombatende Beres, Laura K. Simbeza, Sandra Mukamba, Njekwa Eshun-Wilson, Ingrid Schwartz, Sheree Pry, Jake Padian, Nancy Holmes, Charles B.
...
Published in
Journal of Acquired Immune Deficiency Syndromes (1999)
Background: Patients report varied barriers to HIV care across multiple domains, but specific barrier patterns may be driven by underlying, but unobserved, behavioral profiles. Methods: We traced a probability sample of patients lost to follow-up (>90 days late) as of July 31, 2015 from 64 clinics in Zambia. Among those found alive, we ascertained ...
Verheij, Eveline Wit, Ferdinand W. Verboeket, Sebastiaan O. Schim van der Loeff, Maarten F. Nellen, Jeannine F. Reiss, Peter Kirk, Gregory D.
Published in
Journal of Acquired Immune Deficiency Syndromes (1999)
Background: We previously demonstrated a higher prevalence of frailty among AGEhIV-cohort participants with HIV (PWH) than among age- and lifestyle-comparable HIV-negative participants. Furthermore, frailty was associated with the development of comorbidities and mortality. As frailty may be a dynamic state, we evaluated the frequency of transition...
Weiser, John K. Tie, Yunfeng Beer, Linda Neblett Fanfair, Robyn Shouse, Roy Luke
Published in
Journal of Acquired Immune Deficiency Syndromes (1999)
Health inequities among people with HIV may be compounded by disparities in the prevalence of comorbidities associated with an increased risk of severe illness from COVID-19. Setting: Complex sample survey designed to produce nationally representative estimates of behavioral and clinical characteristics of adults with diagnosed HIV in the United St...
Martin, Elizabeth Anne Lai, Ming-Tain Ngo, Winnie Feng, Meizhen Graham, Donald Hazuda, Daria J Kumar, Sushma Hwang, Carey Sklar, Peter Asante-Appiah, Ernest
...
Published in
Journal of acquired immune deficiency syndromes (1999)
Doravirine (DOR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) approved for the treatment of HIV-1 infection in patients with no known DOR resistance-associated mutations. DOR was rationally designed to address limitations associated with other approved NNRTIs, particularly resistance from common NNRTI resistance-associated muta...
Dean, Lorraine T Nonyane, Bareng Aletta Sanny Ugoji, Chinenye Visvanathan, Kala Jacobson, Lisa P Lau, Bryan
Published in
Journal of acquired immune deficiency syndromes (1999)
With HIV now considered a chronic disease, economic burden for people living with HIV (LWH) may threaten long-term disease outcomes. We studied associations between economic burden (employment, income, insurance, and financial difficulty) and HIV status for gay, bisexual, and other men who have sex with men (GBMSM) and how economic burden relates t...
Jean Louis, Frantz Domercant, Jean Wysler Ignacio, Caroline Gianella, Sara Galbaud, Guethina Leonard, Maureen Smith, Davey M Chaillon, Antoine
Published in
Journal of acquired immune deficiency syndromes (1999)
In low HIV prevalence settings, understanding the transmission dynamics and the impact of drug resistance is critical to curb down the epidemic. This study aims to explore the prevalence and dynamics of transmission of HIV drug-resistance mutations (DRMs) among key populations in Haiti. Eligible participants (naive, treated) were selected from 7 ke...
Rizzardini, Giuliano Overton, Edgar T Orkin, Chloe Swindells, Susan Arasteh, Keikawus Górgolas Hernández-Mora, Miguel Pokrovsky, Vadim Girard, Pierre-Marie Oka, Shinichi Andrade-Villanueva, Jaime F
...
Published in
Journal of acquired immune deficiency syndromes (1999)
Long-acting (LA) injectable regimens are a potential therapeutic option in people living with HIV-1. ATLAS (NCT02951052) and FLAIR (NCT02938520) were 2 randomized, open-label, multicenter, multinational phase 3 studies. Adult participants with virologic suppression (plasma HIV-1 RNA
Ehrenkranz, Peter Grimsrud, Anna Holmes, Charles B Preko, Peter Rabkin, Miriam
Published in
Journal of acquired immune deficiency syndromes (1999)
Simplifying antiretroviral therapy (ART) for clinically stable people living with HIV (PLHIV) is important but insufficient to meet their healthcare needs, including prevention and treatment of tuberculosis (TB) and non-communicable diseases (NCDs), routine primary care, and family planning (FP). Integrating these services into differentiated servi...
